On June 17, 2024, Margaret Horn, Chief Operating Officer of Revolution Medicines Inc (NASDAQ:RVMD), executed a sale of 4,415 shares of the company. According to the SEC Filing, the transaction was carried out at a stock price of $37.39 per share. Over the past year, Margaret Horn has sold a total of 93,609 shares and has not made any purchases of the company's stock.
Key Insights Revolution Medicines will host its Annual General Meeting on 20th of June Total pay for CEO Mark Goldsmith...
REDWOOD CITY, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairman, will be a featured speaker in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference. Details of the company’s participation are as follows: Goldman Sachs 45th Annual Gl